These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36508157)

  • 1. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
    Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J
    Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study.
    Akpinar EO; Liem RSL; Nienhuijs SW; Greve JWM; Marang-van de Mheen PJ;
    Surg Obes Relat Dis; 2021 Jul; 17(7):1349-1358. PubMed ID: 33762128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
    Seeberg KA; Borgeraas H; Hofsø D; Småstuen MC; Kvan NP; Grimnes JO; Lindberg M; Fatima F; Seeberg LT; Sandbu R; Hjelmesæth J; Hertel JK
    Ann Intern Med; 2022 Jan; 175(1):74-83. PubMed ID: 34843380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
    Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
    BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy.
    Aminian A
    Surg Obes Relat Dis; 2020 Feb; 16(2):332-339. PubMed ID: 31902579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the individualized metabolic surgery score for bariatric procedure selection in the merged data of two randomized clinical trials (SLEEVEPASS and SM-BOSS).
    Saarinen I; Grönroos S; Hurme S; Peterli R; Helmiö M; Bueter M; Strandberg M; Wölnerhanssen BK; Salminen P
    Surg Obes Relat Dis; 2023 May; 19(5):522-529. PubMed ID: 36503734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACCURACY OF ELASTOGRAPHY IN THE ASSESSMENT OF REDUCTION IN LIVER STEATOSIS AND FIBROSIS IN THE EARLY POSTOPERATIVE PERIOD AFTER BARIATRIC SURGERY.
    Lima RR; Garcia JHP; Studart MS; Pinheiro FS; Pinto JOG; Sales LA; Soares LM; Santos PA
    Arq Bras Cir Dig; 2022; 35():e1671. PubMed ID: 36043649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial.
    Lin S; Li C; Shen J; Guan W; Liang H
    Surg Obes Relat Dis; 2022 Nov; 18(11):1277-1285. PubMed ID: 35985975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery.
    Vangoitsenhoven R; Wilson RL; Cherla DV; Tu C; Kashyap SR; Cummings DE; Schauer PR; Aminian A
    Diabetes Care; 2021 Feb; 44(2):321-325. PubMed ID: 33323476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting relapse of type 2 diabetes after bariatric surgery in Sweden 2007-2015: a registry-based cohort study.
    Jans A; Szabo E; Näslund I; Ottosson J; Näslund E; Stenberg E
    Surg Obes Relat Dis; 2022 Mar; 18(3):305-312. PubMed ID: 34974997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D): Study rationale, design, and methods.
    Simonson DC; Hu B; Arterburn DE; Schauer PR; Kashyap SR; Courcoulas AP; Cummings DE; Patti ME; Gourash WF; Vernon AH; Jakicic JM; Kirwan JP
    Diabetes Obes Metab; 2022 Jul; 24(7):1206-1215. PubMed ID: 35233923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.
    Murphy R; Tsai P; Jüllig M; Liu A; Plank L; Booth M
    Obes Surg; 2017 Apr; 27(4):917-925. PubMed ID: 27738970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
    Wallenius V; Alaraj A; Björnfot N; Orrenius B; Kylebäck A; Björklund P; Werling M; Thorell A; Fändriks L; Maleckas A
    Surg Obes Relat Dis; 2020 Aug; 16(8):1035-1044. PubMed ID: 32540150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.
    Castro MJ; Jimenez JM; Carbajo MA; Lopez M; Cao MJ; Garcia S; Ruiz-Tovar J
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.